[ad_1]
CHARLESTON, S.C. – These are the little things Jon Lubecky enjoys now, like playing a board game with his family. But this was not always the case for the former army sniper, who returned home in 2006 after nearly a year in Iraq with a traumatic brain injury due to a mortar attack and a post-traumatic disorder. Traditional treatments, including the use of antidepressants like Zoloft, were useless.
"I went home, I loaded a nine millimeter Beretta, I put it in my temple and pulled the trigger," said Lubecky.
"The greatest peace I've ever felt was that the microsecond hammer fell … I knew it was over."
The gun malfunctioned, but he would try again and again.
CBS News
Lubecky's latest suicide attempt took place on November 3, 2013. Sixteen months later, his MDMA-assisted therapy regiment was completed. So, do not talk to Lubecky if you think that the classification of MDMA as a controlled substance makes it inappropriate for the treatment of PTSD.
"If I told you," I have a treatment that eliminates tumors in 68% of cancer patients, they would pass a bill tomorrow by legalizing it, "said Lubecky.
MDMA-assisted therapy is now about to begin its third phase of FDA testing. It will take another three years and up to 300 additional subjects. But if all goes well, MDMA will be available by prescription from 2021.